Guerra, Tommaso
Caputo, Francesca
Orlando, Bianca
Paolicelli, Damiano
Trojano, Maria
Iaffaldano, Pietro http://orcid.org/0000-0003-2308-1731
Funding for this research was provided by:
Università degli Studi di Bari Aldo Moro
Article History
Received: 10 September 2020
Accepted: 18 February 2021
First Online: 6 March 2021
Declarations
:
: All the data about MS history, demographics, treatments and regular follow up of the MS patients followed at the Multiple Sclerosis Center of the University Hospital Policlinico of Bari are collected, according to the Italian MS Registry study, which was approved by the ethical commitee at the “Azienda Ospedaliero-Universitaria-Policlinico di Bari” using the iMed software. According to the Registry rules, on February 5th 2018, the Scientific Commitee of the Italian MS Registry granted the approval to conduct this project and extract and use the registry data.
: Pietro Iaffaldano has served on scientific advisory boards for Biogen Idec and has received funding for travel and/or speaker honoraria from Sanofi-Aventis, Biogen Idec, Teva, and Novartis. Damiano Paolicelli received honoraria for consultancy and/or speaking from Biogen Idec, Merck-Serono, Sanofi-Aventis, TEVA, Novartis, and Genzyme. Maria Trojano has received honoraria for consultancy or speaking from Biogen, Sanofi-Aventis, Merck Serono, and Bayer-Schering and research grants from Merck Serono, Biogen, and Novartis. There are no conflicts of interest to declare for Tommaso Guerra, Francesca Caputo, and Bianca Orlando.